Pharming Group (PHAR)
NASDAQ:PHAR
Holding PHAR?
Track your performance easily

Pharming Group (PHAR) Technical Analysis

98 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Pharming Group is a Buy.
Pharming Group’s (PHAR) 20-Day exponential moving average is 8.37, while Pharming Group’s (PHAR) share price is $8.1, making it a Sell.
Pharming Group’s (PHAR) 50-Day exponential moving average is 8.31, while Pharming Group’s (PHAR) share price is $8.1, making it a Sell.

Pharming Group (PHAR) Pivot Points

Nov 13, 2024, 11:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.40
7.60
7.80
8.00
8.20
8.40
8.60
Fibonacci
7.60
7.75
7.85
8.00
8.15
8.25
8.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Nov 13, 2024, 11:58 PM
Period
Simple
Exponential
MA5
8.08Sell
8.11Sell
MA10
8.31Sell
8.25Sell
MA20
8.55Sell
8.37Sell
MA50
8.19Sell
8.31Sell
MA100
8.12Sell
8.46Sell
MA200
9.25Sell
9.40Sell
Pharming Group’s (PHAR) 10-Day exponential moving average is 8.25, while Pharming Group’s (PHAR) share price is $8.1, making it a Sell.
Pharming Group’s (PHAR) 100-Day exponential moving average is 8.46, while Pharming Group’s (PHAR) share price is $8.1, making it a Sell.
Pharming Group’s (PHAR) stock price is $8.1 and Pharming Group’s (PHAR) 50-day simple moving average is 8.19, creating a Sell signal.
Pharming Group’s (PHAR) stock price is $8.1 and Pharming Group’s (PHAR) 100-day simple moving average is 8.12, creating a Sell signal.
Pharming Group’s (PHAR) stock price is $8.1 and Pharming Group’s (PHAR) 200-day simple moving average is 9.25, creating a Sell signal.

Pharming Group (PHAR) Technical Indicators

Nov 13, 2024, 11:58 PM
Name
Value
Implied Action
RSI (14)
43.26
Neutral
STOCH (9,6)
23.84
Neutral
STOCHRSI (14)
17.52
Buy
MACD (12,26)
-0.08
Buy
ADX (14)
11.01
Buy
Williams %R
-79.82
Buy
CCI (14)
-98.53
Neutral
ATR (14)
0.49
-
Ultimate Oscillator
40.38
Neutral
ROC
-10.71
Sell
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 43.26, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 11.01, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is -98.53, creating a Neutral signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is -10.71, creating a Sell signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Sell.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 43.26, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is -0.08, which suggests PHAR is a Buy.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 8.08, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 8.55, which suggests PHAR is a Sell.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 8.19, which suggests PHAR is a Sell.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 9.25, which suggests PHAR is a Sell.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -79.82, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is -98.53, which suggests PHAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis